Business Protection For Pharmacies
A pharmacy is one of the few retail businesses that cannot lawfully open without a particular professional present.
The regime sits at two levels: the company carrying on the business needs a superintendent pharmacist, and each registered premises needs a responsible pharmacist in charge while it operates. Both are named people with recorded responsibilities.
So in a single-site independent, the owner is frequently all of those roles at once, and the business stops when they do.
The short answer
A body corporate carrying on a retail pharmacy business must have a superintendent pharmacist, and each registered premises must have a responsible pharmacist in charge when it is operating. Losing the superintendent is therefore a legal obstacle to trading rather than a staffing gap, and the General Pharmaceutical Council must be notified. Key person cover provides the money to engage locum and interim cover and recruit at short notice.
Superintendent And Responsible Pharmacist Are Both Named Roles
Where a company carries on a retail pharmacy business, it must have a superintendent pharmacist, a registered pharmacist responsible for the professional aspects of the business, and the General Pharmaceutical Council holds that information. Separately, registered premises must have a responsible pharmacist in charge while they are operating.
If the superintendent dies or becomes unable to act, the company no longer meets a requirement of lawfully carrying on the business, and the GPhC must be notified. What is acceptable in the interim and over what period is for the GPhC and the relevant regulations rather than for us.
The day to day effect is more immediate than in most sectors. Without a responsible pharmacist in charge, the pharmacy cannot operate normally, so prescriptions are not dispensed, NHS contract obligations are not met and patients go elsewhere, from the first day rather than after a period of grace.
None of this is regulatory advice. The GPhC, the NHS commissioner and a sector adviser are the right first calls, and the insurance is the funding side of the same problem.
What happens in the weeks afterwards
- 1The GPhC is notified, and the NHS commissioner will need to know about any interruption to service
- 2Locum cover is arranged immediately so the premises can operate at all, at locum rates
- 3A superintendent arrangement has to be put in place for the company, which is a different and harder appointment
- 4Recruitment begins for a permanent replacement, in a market where locum rates have been volatile
- 5Staff wages, rent, stock finance and any loan on the business continue throughout
- 6If the person lost was the owner, their shareholding must be resolved, and a buyer or successor pharmacist is needed rather than simply a buyer
The Revenue Stops On Day One
This sector is unusual in how quickly the loss translates into no income at all, and it changes the sizing of cover.
Many businesses can run for weeks on momentum after losing a key person. A pharmacy without a responsible pharmacist in charge cannot operate normally, so dispensing stops immediately, the NHS contract work is not being done, and patients take their repeat prescriptions somewhere else. Repeat patients are habit-driven and do not reliably come back.
So the money needs to be available fast and in enough quantity to pay locum rates from the first week. That is an argument for sizing key person cover against the real cost of keeping the doors open rather than against a notional profit figure.
A Family Cannot Simply Inherit A Pharmacy
This is the succession point that makes shareholder protection matter more here than in an unregulated trade.
If an owner-pharmacist dies, their shares pass to their estate, and a spouse or child who is not a pharmacist cannot step into the professional roles. The business needs a pharmacist, which means either employing one on terms that work, or selling.
A cross-option arrangement backed by life cover gives the surviving owners the money to buy the share and the family a fair price, instead of a forced sale of a business that is losing patients by the week. The shareholder protection page covers how those agreements work.
Which cover does what here
The direct fit. Funds immediate locum cover so the premises can open, the harder superintendent appointment, and recruitment, at the rates a short-notice market commands.
An independent pharmacy cannot simply be inherited and run by a family member who is not a pharmacist. This provides the money for the survivors to buy the share, which in this sector may also mean buying in a pharmacist.
Pharmacy acquisitions are usually debt funded and the goodwill is often substantial, so the loan is a large liability that continues while the business cannot trade normally.
The personal side. Where the company employs the pharmacist, it can hold life cover on them rather than them funding it from taxed income.
Worth reading next
Common questions
What happens if a pharmacy's superintendent pharmacist dies?+
The company no longer meets a requirement of lawfully carrying on a retail pharmacy business, so the GPhC must be notified. Separately, the premises needs a responsible pharmacist in charge to operate, so locum cover is usually needed immediately.
Can the pharmacy stay open in the meantime?+
Only with a responsible pharmacist in charge, which in practice means locum cover from day one. That is why this sector needs money available fast rather than after a long deferred period.
Can my family inherit the pharmacy?+
They can inherit the shares, and they cannot hold the professional roles unless they are pharmacists. In practice the business needs a pharmacist employed on workable terms or it needs selling, which is why a cross-option arrangement matters here.
How much key person cover does an independent pharmacy need?+
Enough to fund locum cover at short-notice rates from the first week, a superintendent arrangement, and recruitment, alongside rent, wages and stock finance. Sizing it against notional profit understates it.
Is the goodwill loan covered by this?+
That is business loan protection rather than key person cover, and the two are sized differently. Pharmacy acquisitions are usually debt funded with substantial goodwill, so the loan is often the largest single liability.